Bookmark and Share
cyromazine (CID 47866) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(4)
 
 
Inactive(357)
 
 
Inconclusive(36)
 
 
Unspecified(154)
 
 
Top Targets:
NR LBD PPAR(29)
 
 
 
NR LBD ER(25)
 
 
 
 
NR LBD AR(24)
 
 
 
 
7TM GPCR Srsx(17)
 
 
 
7TM GPCR Srx(16)
 
 
BioAssay Types:
Confirmatory(367)
 
 
 
 
 
Literature(84)
 
 
 
Summary(72)
 
 
 
 
Screening(2)
 
 
BioActivity Types:
Potency(304)
 
 
 
 
IC50(116)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 308    Data Row: 551   Total Pages: 28   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID144211101]
Potency-Replicate_1 43.6412qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen [AID743224, Type: confirmatory]
View
2
[SID144211101]
Potency-Replicate_1 48.9662qHTS assay for small molecule activators of the heat shock response signaling pathway [AID743210, Type: confirmatory]heat shock protein beta-1 [Homo sapiens] [gi:4504517]
View
3
[SID144209044]
AhR Potency (uM) 58.0045qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary [AID743122, Type: summary]aryl hydrocarbon receptor [Homo sapiens] [gi:51095037]
View
4
[SID144211101]
Potency-Replicate_1 61.1306qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line [AID743015, Type: confirmatory]
View
5
[SID26757209]
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other]
View
6
[SID104247295]
Drug level in leaf of Gerbera jamesonii grown in closed hydroponic system assessed per fresh weight at 750 mg/l applied through nutrient solution measured on day 121 post-treatment in winter by gas chromatographic analysis [AID1092995, Type: Literature]
View
7
[SID104247295]
Drug level in leaf of Gerbera jamesonii grown in closed hydroponic system assessed per fresh weight at 375 mg/l applied through nutrient solution measured on day 121 post-treatment in winter by gas chromatographic analysis [AID1092996, Type: Literature]
View
8
[SID104247295]
Drug level in leaf of Gerbera jamesonii grown in closed hydroponic system assessed per fresh weight at 750 mg/l applied through nutrient solution measured on day 56 post-treatment in winter by gas chromatographic analysis [AID1092997, Type: Literature]
View
9
[SID104247295]
Drug level in leaf of Gerbera jamesonii grown in closed hydroponic system assessed per fresh weight at 375 mg/l applied through nutrient solution measured on day 56 post-treatment in winter by gas chromatographic analysis [AID1092998, Type: Literature]
View
10
[SID104247295]
Drug level in root of Gerbera jamesonii grown in closed hydroponic system assessed per fresh weight at 750 mg/l applied through nutrient solution measured on day 121 post-treatment in winter by gas chromatographic analysis [AID1092999, Type: Literature]
View
11
[SID104247295]
Drug level in root of Gerbera jamesonii grown in closed hydroponic system assessed per fresh weight at 375 mg/l applied through nutrient solution measured on day 121 post-treatment in winter by gas chromatographic analysis [AID1093000, Type: Literature]
View
12
[SID104247295]
Drug level in root of Gerbera jamesonii grown in closed hydroponic system assessed per fresh weight at 750 mg/l applied through nutrient solution measured on day 17 post-treatment in winter by gas chromatographic analysis [AID1093001, Type: Literature]
View
13
[SID104247295]
Drug level in root of Gerbera jamesonii grown in closed hydroponic system assessed per fresh weight at 375 mg/l applied through nutrient solution measured on day 17 post-treatment in winter by gas chromatographic analysis [AID1093002, Type: Literature]
View
14
[SID104247295]
IC50 DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) [AID625191, Type: confirmatory]5-hydroxytryptamine receptor 1B [gi:112815]
View
15
[SID104247295]
IC50 DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) [AID625218, Type: confirmatory]5-hydroxytryptamine receptor 2C [gi:112816]
View
16
[SID104247295]
IC50 DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine) [AID625193, Type: confirmatory]Acetylcholinesterase [gi:113037]
View
17
[SID104247295]
IC50 DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625151, Type: confirmatory]Muscarinic acetylcholine receptor M1 [gi:113118]
View
18
[SID104247295]
IC50 DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625152, Type: confirmatory]Muscarinic acetylcholine receptor M2 [gi:113122]
View
19
[SID104247295]
IC50 DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625153, Type: confirmatory]Muscarinic acetylcholine receptor M3 [gi:113125]
View
20
[SID104247295]
IC50 DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) [AID625228, Type: confirmatory]Androgen receptor [gi:113832]
View